Salt Lake City, UT, USA, 02/11/2016 /SubmitPressRelease123/
Taiwan now treating cancer patients with Hyperthermia in New Taipei City
After passing the rigorous clearance process with the TFDA, (Taiwan Food and Drug Administration), a Pyrexar BSD-2000 Deep Regional Hyperthermia system is now installed and treating patients at MacKay Memorial Hospital in New Taipei City, Taiwan. Hyperthermia cancer treatment involves localized heating of cancer tumors using RF energy to a target temperature of 42C. This process is clinically proven to make cancer cells more sensitive to chemotherapy, radiotherapy, and immunotherapy treatments.
News Source: http://www.WiredPRNews.com
